Picture of Star Combo Pharma logo

S66 — Star Combo Pharma News Story

0.000.00%
au flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapContrarian

Brief: Star Combo Pharma Says HY Operating Loss Attributable A$4.4 Million

Feb 27 (Reuters) - Star Combo Pharma Ltd  S66.AX :
    * HY OPERATING LOSS ATTRIBUTABLE A$4.4 MILLION VERSUS LOSS
A$997
    * HY REVENUE A$11.6 MILLION VERSUS A$11.8 MILLION
    * BUSINESS STRATEGY IN FY23 REMAINS FOCUSED ON GROWING ITS
CONTRACT MANUFACTURING OPERATIONS

Source text for Eikon:  ID:nASX50xfbh 
Further company coverage:  S66.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Star Combo Pharma

See all news